DK499175A - Fremgangsmade til fremstilling af derivater af oxathiino-(1,4)-(2,3-c)-pyrrol - Google Patents

Fremgangsmade til fremstilling af derivater af oxathiino-(1,4)-(2,3-c)-pyrrol

Info

Publication number
DK499175A
DK499175A DK499175A DK499175A DK499175A DK 499175 A DK499175 A DK 499175A DK 499175 A DK499175 A DK 499175A DK 499175 A DK499175 A DK 499175A DK 499175 A DK499175 A DK 499175A
Authority
DK
Denmark
Prior art keywords
oxathiino
procedure
preparation
pyrrol derivatives
pyrrol
Prior art date
Application number
DK499175A
Other languages
Danish (da)
English (en)
Inventor
M Barreau
C Cotrel
C Jeanmart
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of DK499175A publication Critical patent/DK499175A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
DK499175A 1974-11-07 1975-11-06 Fremgangsmade til fremstilling af derivater af oxathiino-(1,4)-(2,3-c)-pyrrol DK499175A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7436962A FR2290208A1 (fr) 1974-11-07 1974-11-07 Nouveaux derives de l'oxathiinno(1,4)(2,3-c)pyrrole, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
DK499175A true DK499175A (da) 1976-05-08

Family

ID=9144747

Family Applications (1)

Application Number Title Priority Date Filing Date
DK499175A DK499175A (da) 1974-11-07 1975-11-06 Fremgangsmade til fremstilling af derivater af oxathiino-(1,4)-(2,3-c)-pyrrol

Country Status (28)

Country Link
US (1) US4021554A (sv)
JP (2) JPS6029716B2 (sv)
AR (2) AR214045A1 (sv)
AT (1) AT342603B (sv)
AU (1) AU503381B2 (sv)
BE (1) BE835324A (sv)
CA (1) CA1054599A (sv)
CH (2) CH608238A5 (sv)
CS (1) CS191285B2 (sv)
DD (1) DD122541A5 (sv)
DE (1) DE2550163C2 (sv)
DK (1) DK499175A (sv)
ES (2) ES442441A1 (sv)
FI (1) FI59251C (sv)
FR (1) FR2290208A1 (sv)
GB (1) GB1466829A (sv)
HU (1) HU170500B (sv)
IE (1) IE42030B1 (sv)
IL (1) IL48422A (sv)
LU (1) LU73737A1 (sv)
NL (1) NL7512731A (sv)
NO (1) NO143534C (sv)
OA (1) OA05141A (sv)
PH (1) PH14755A (sv)
SE (1) SE419222B (sv)
SU (2) SU576949A3 (sv)
YU (2) YU281175A (sv)
ZA (1) ZA756953B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1072557A (fr) * 1976-02-20 1980-02-26 Rhone-Poulenc Industries Derives du dithiepinno (1,4)(2,3-c) pyrrole, leur preparation et les compositions qui les contiennent
FR2525605A1 (fr) * 1982-04-22 1983-10-28 Rhone Poulenc Sante Nouveaux derives du dithiinno (1,4) (2,3-c) pyrrole, leur preparation et les medicaments qui les contiennent
FR2607504B1 (fr) * 1986-12-02 1989-01-27 Rhone Poulenc Sante Nouveaux derives de l'isoindolinone, leur preparation et les compositions pharmaceutiques qui les contiennent
NZ581544A (en) * 2007-05-31 2012-06-29 Glycan Biosciences Sulphated xylans for treatment or prophylaxis of respiratory diseases

Also Published As

Publication number Publication date
ES442441A1 (es) 1977-04-01
AU503381B2 (en) 1979-08-30
FI59251C (fi) 1981-07-10
CH608808A5 (sv) 1979-01-31
DE2550163A1 (de) 1976-05-20
PH14755A (en) 1981-11-20
IE42030B1 (en) 1980-05-21
CA1054599A (fr) 1979-05-15
IE42030L (en) 1976-05-07
JPS60222484A (ja) 1985-11-07
SU576949A3 (ru) 1977-10-15
OA05141A (fr) 1981-01-31
US4021554A (en) 1977-05-03
JPS6029716B2 (ja) 1985-07-12
ES442442A1 (es) 1977-07-01
CS191285B2 (en) 1979-06-29
AU8633275A (en) 1977-05-12
SE7512476L (sv) 1976-05-10
AR214400A1 (es) 1979-06-15
GB1466829A (en) 1977-03-09
CH608238A5 (sv) 1978-12-29
NO753712L (sv) 1976-05-10
NO143534C (no) 1981-03-04
LU73737A1 (sv) 1976-09-06
AR214045A1 (es) 1979-04-30
SE419222B (sv) 1981-07-20
BE835324A (fr) 1976-05-06
NL7512731A (nl) 1976-05-11
YU281175A (en) 1982-08-31
FR2290208A1 (fr) 1976-06-04
DD122541A5 (sv) 1976-10-12
FI753126A (sv) 1976-05-08
ZA756953B (en) 1976-10-27
JPS5170792A (en) 1976-06-18
IL48422A (en) 1979-03-12
ATA848575A (de) 1977-08-15
HU170500B (sv) 1977-06-28
FR2290208B1 (sv) 1978-07-28
IL48422A0 (en) 1976-01-30
AT342603B (de) 1978-04-10
SU615860A3 (ru) 1978-07-15
YU108082A (en) 1982-08-31
JPS6111954B2 (sv) 1986-04-05
NO143534B (no) 1980-11-24
FI59251B (fi) 1981-03-31
DE2550163C2 (de) 1984-11-22

Similar Documents

Publication Publication Date Title
DK298176A (da) Fremgangsmade til fremstilling af 1,4-dihydropyrinderivater
DK283175A (da) Fremgangsmade til fremstilling af benzocycloamid-derivater
DK239075A (da) Fremgangsmade til fremstilling af iodbenzenderivater
DK164376A (da) Fremgangsmade til fremstilling af 3,4-dihydrospiro-2h-1,3-benzoxaziner
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
DK356375A (da) Fremgangsmade til fremstilling af 2-thiol-4,5-diphenyloxazol-s-derivater
DK547475A (da) Fremgangsmade til fremstilling af 8,8-disubstituerede 6-methylergoliner
DK211075A (da) Fremgangsmade til fremstilling af abietamidderivater
DK145696C (da) Fremgangsmaade til fremstilling af 2-arylamino-2-imidazolin-derivater
DK376975A (da) Fremgangsmade til fremstilling af abietamidderivater
DK552675A (da) Fremgangsmade til fremstilling af 2-acyl-4-oxopyrazinoisoquinolinderivater
DK271975A (da) Fremgangsmade til fremstilling af acylderivater
DK499175A (da) Fremgangsmade til fremstilling af derivater af oxathiino-(1,4)-(2,3-c)-pyrrol
DK198175A (da) Fremgangsmade til fremstilling af indolkinolizidinderivater
DK71877A (da) Fremgangsmade til fremstilling af derivater af dithiepino-(1,4) (2,3-c)-pyrrol
DK149803C (da) Fremgangsmaade til fremstilling af 1,2-dichlorethan
DK544476A (da) Fremgangsmade til fremstilling af difluormethyl-1,2,2-trifluorethylether
DK348575A (da) Fremgangsmade til fremstilling af 9,11,15-trihydroxy-13,14-dehydro-prostaglandiner
DK305076A (da) Fremgangsmade til fremstilling af d,l-pantolacton
DK132661C (da) Fremgangsmade til fremstilling af 17-acylestere af 17alfa,21-dihydroxysteroider af pregnanrekken
DK143939C (da) Fremgangsmaade til fremstilling af prostaglandin-fbeta-derivater
DK507275A (da) Fremgangsmade til fremstilling af aminomethylarylmethylpenicillin-derivater
DK515875A (da) Fremgangsmade til fremstilling af 7alfa-alkoxycephalosporin-derivater
DK554176A (da) Fremgangsmade til fremstilling af 3,4-dideoxykanamycin b
DK139269B (da) Fremgangsmaade til fremstilling af 4-androsten3,17-dionderivatier